Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregory P. Sutton, MD
St. Vincent Gynecologic Oncology at St. Vincent Oncology Center
- Martee L. Hensley, MD
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Kaiser Permanente Medical Center - Los Angeles
Los Angeles, California, United States
- Helen and Harry Gray Cancer Center at Hartford Hospital
Hartford, Connecticut, United States
- New Britain General Hospital
New Britain, Connecticut, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Mbccop-Medical College of Georgia Cancer Center
Augusta, Georgia, United States
- Medical Center of Central Georgia
Macon, Georgia, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Woman'S Hospital
Baton Rouge, Louisiana, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia
Columbia, Missouri, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
- Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, United States
- St. John'S Regional Health Center
Springfield, Missouri, United States
- Siteman Cancer Center at Barnes-Jewish Hospital
St Louis, Missouri, United States
- Methodist Cancer Center at Methodist Hospital - Omaha
Omaha, Nebraska, United States
- Fox Chase Virtua Health Cancer Program - Marlton
Marlton, New Jersey, United States
- Umdnj University Hospital
Newark, New Jersey, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Fox Chase Virtua Health Cancer Program at Virtua West Jersey
Voorhees Township, New Jersey, United States
- University of New Mexico Cancer Research and Treatment Center
Albuquerque, New Mexico, United States
- New York Oncology Hematology, Pc at Albany Regional Cancer Care
Albany, New York, United States
- Suny Downstate Medical Center
Brooklyn, New York, United States
- Stony Brook University Cancer Center
Stony Brook, New York, United States
- Hope A Women'S Cancer Center
Asheville, North Carolina, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Forsyth Regional Cancer Center at Forsyth Medical Center
Winston-Salem, North Carolina, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2003
- Primary completion
- 31 Jul 2006
- Completion
- —
- Last update posted
- 14 Feb 2014
- Registered enrollment
- —
- Registry id
- NCT00101127
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.